Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 35 results for "cadila pharma"

Pharma stocks see relief rally; index up 3 pct
Sify

Cadila among few bright spots in pharma space

Unlike many of its pharma peers, there has been a slew of goods news for Cadila Healthcare in recent times. While its Moraiya plant recently got clearance of the US FDA, Cadila has also received almost a dozen approvals for new launches in the US since ... Business Standard, 2 weeks ago

27 images for cadila pharma

Money Control, 1 day ago
Money Control, 2 weeks ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 month ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard

Zydus Cadila gets final nod from USFDA for doxycycline tablets

The company will manufacture the drug at the group's formulations facility at the pharma SEZ in Ahmedabad
 Business Standard3 weeks ago Zydus' Nesher Pharma gets USFDA nod to market influenza drug  Business Standard1 month ago Cadila in the pink of health after company gets USFDA nod to market Ziprasidone  Sify1 month ago

Zydus and Pharm Aid tie up for vaccine technology for Russia

Cadila Healthcare Limited (Zydus Cadila), has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd, headquartered in Russia. Pharm Aid Ltd, has been set up by Nacimbio ...
 Business Standard1 month ago Zydus Cadila's Q1 consolidated net profit up 15%  Prokerala2 months ago Cadila Healthcare Q1 PAT down 30% as GST hurts domestic business  Business Standard2 months ago
Money Control

Pharma wrap: Dr Reddy#39;s German observation, Cadila clearing US inspection more

The sector was kept busy with Dr Reddy#39;s German regulator observations, Cadila Healthcare clearing US FDA inspection with zero observations, Biocon getting EU-GMP for Malaysia insulins facility and Novartis naming Indian-origin Vas Narasimhan as its CEO.
 Money Control1 month ago
Money Control

This week in pharma: Lupin, Cadila, Strides Shasun get clearances from US FDA

The BSE Healthcare index gained 0.96 percent in the past week, the benchmark Sensex rose 0.43 percent.
 Money Control1 month ago

Flat Finish to the Week; Cadila Healthcare Rallies 7%

Posted by Equitymaster Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks , software stocks and capital good stocks . At the closing bell, the BSE Sensex closed higher by 28 points and the NSE Nifty ...
 Equitymaster.com1 month ago Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today  Equitymaster.com2 months ago Sensex Surges in Afternoon Session; Metal Stocks Top Gainers  Equitymaster.com1 week ago US Fed Meet, SBI Life IPO and Other Top Cues in Action Today  Equitymaster.com1 month ago

No bitter pill for Caplin, Natco and Cadila

While most pharma firms suffer, investors cheer some with good product pipeline and improving regulatory record
 Business Standard1 week ago

Glenmark's Glenn Saldanha appointed IPA President

Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, today said Glenn Saldanha has been appointed as President for 2017-19.Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.IPA also appointed Panacea Biotec Joint ...
 Business Standard6 days ago

Likely competition for generic Lialda bears on Cadila's stocks

Copy Begins/Cadila Healthcare's (Zydus Cadila) blockbuster drug the generic version of mesalamine (Lialda) is likely to face competition from the innovator itself as Irish pharma firm Shire Plc is expected to launch an authorised generic (AG) version of the ...
 Business Standard1 month ago Father and son Transform Cadila Health to a world beater  The Financial Chronicle2 months ago
Sify

Pharma stocks in demand as investors react to some positive news

From a low of around 12,500 it touched on 11 August 2017, the BSE Healthcare Index gained more than 6.2% (at today's high of 13,268.53), but it still stays a long way behind the 52-week high of 16,865.85 it had touched in early September 2016. Most of the ...
 Sify1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less